Santa Rosa-based Trivascular, a developer of medical stent graft systems for treating aortic aneurysms, said this week that it has raised $60M in a Series C funding round. The round was led by Pinnacle Ventures, and also included New Enterprise Associates (NEA), Delphi Ventures, MPM Capital and Kearny Venture Partners. As part of the investment, Pinnacle's David J. Kim and NEA's Ryan Drant have both joined the firm's board. The firm said the funding will go toward launching its Ovation Abdominal Stent Graft System in Europe.
posted on Tuesday, July 13, 2010 (Link to more information) Related companies: Trivascular Related stories: > Trivascular Snags $30M > Artimi Raises $26.5M > Barosense Raises $27.4M > Twitter Raises $200M > Market6 Raises $5.5M silicontap.com Home